Cargando…

Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study

OBJECTIVE: An unknown portion of women with silicone breast implants (SBI) report development of systemic symptoms, recently named as ‘breast implant illness (BII)’. We aim to describe the symptoms and characteristics of women with SBI reporting these systemic symptoms and compare the clinical cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Spit, Karlinde Amber, Scharff, Miranda, de Blok, Christel JM, Niessen, Frank B, Bachour, Yara, Nanayakkara, Prabath W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185500/
https://www.ncbi.nlm.nih.gov/pubmed/35680258
http://dx.doi.org/10.1136/bmjopen-2021-057159
_version_ 1784724738016280576
author Spit, Karlinde Amber
Scharff, Miranda
de Blok, Christel JM
Niessen, Frank B
Bachour, Yara
Nanayakkara, Prabath W
author_facet Spit, Karlinde Amber
Scharff, Miranda
de Blok, Christel JM
Niessen, Frank B
Bachour, Yara
Nanayakkara, Prabath W
author_sort Spit, Karlinde Amber
collection PubMed
description OBJECTIVE: An unknown portion of women with silicone breast implants (SBI) report development of systemic symptoms, recently named as ‘breast implant illness (BII)’. We aim to describe the symptoms and characteristics of women with SBI reporting these systemic symptoms and compare the clinical course of women who chose to keep their implants, to women who had their implants removed. DESIGN: Observational cohort study. SETTING: Specialised BII out-patient clinic at Amsterdam UMC, the Netherlands, from 2011 to 2020. PARTICIPANTS: All women presenting to the BII clinic with SBI and systemic symptoms. RESULTS: 467 women were included for baseline analyses and 398 women for follow-up. Most frequently reported systemic symptoms at baseline included fatigue (88%), arthralgia (71%), morning stiffness (59%), myalgia (48%), cognitive impairment (33%), peripheral neurological symptoms (30%) and lymphadenopathy (22%). Furthermore, 56% reported pre-existing allergies at baseline and positive antinuclear antibodies were observed in 23%. At follow-up with a median of 3.3 years (IQR 2–4), 152 women had their implants removed on clinical grounds. Symptoms improved significantly in 65 women (43%), improved moderately in 37 women (24%), did not change in 37 women (24%) and deteriorated in 13 women (9%). Women who underwent explantation showed more improvement of their systemic symptoms compared with women who did not (OR 2.9, 95% CI 1.3 to 6.2). Additionally, women who underwent explantation within 10 years after implantation improved significantly better than women who got the implants removed after 10 years (p=0.007). Lastly, local symptoms decreased from 75% to 34% after implant removal (p<0.0001). CONCLUSION: Most women with SBI who developed systemic symptoms experienced improvement after explantation, especially when removed within 10 years after implantation. Early recognition of the pattern of systemic symptoms in women with SBI is important and implant removal should be considered.
format Online
Article
Text
id pubmed-9185500
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-91855002022-06-16 Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study Spit, Karlinde Amber Scharff, Miranda de Blok, Christel JM Niessen, Frank B Bachour, Yara Nanayakkara, Prabath W BMJ Open Immunology (Including Allergy) OBJECTIVE: An unknown portion of women with silicone breast implants (SBI) report development of systemic symptoms, recently named as ‘breast implant illness (BII)’. We aim to describe the symptoms and characteristics of women with SBI reporting these systemic symptoms and compare the clinical course of women who chose to keep their implants, to women who had their implants removed. DESIGN: Observational cohort study. SETTING: Specialised BII out-patient clinic at Amsterdam UMC, the Netherlands, from 2011 to 2020. PARTICIPANTS: All women presenting to the BII clinic with SBI and systemic symptoms. RESULTS: 467 women were included for baseline analyses and 398 women for follow-up. Most frequently reported systemic symptoms at baseline included fatigue (88%), arthralgia (71%), morning stiffness (59%), myalgia (48%), cognitive impairment (33%), peripheral neurological symptoms (30%) and lymphadenopathy (22%). Furthermore, 56% reported pre-existing allergies at baseline and positive antinuclear antibodies were observed in 23%. At follow-up with a median of 3.3 years (IQR 2–4), 152 women had their implants removed on clinical grounds. Symptoms improved significantly in 65 women (43%), improved moderately in 37 women (24%), did not change in 37 women (24%) and deteriorated in 13 women (9%). Women who underwent explantation showed more improvement of their systemic symptoms compared with women who did not (OR 2.9, 95% CI 1.3 to 6.2). Additionally, women who underwent explantation within 10 years after implantation improved significantly better than women who got the implants removed after 10 years (p=0.007). Lastly, local symptoms decreased from 75% to 34% after implant removal (p<0.0001). CONCLUSION: Most women with SBI who developed systemic symptoms experienced improvement after explantation, especially when removed within 10 years after implantation. Early recognition of the pattern of systemic symptoms in women with SBI is important and implant removal should be considered. BMJ Publishing Group 2022-06-09 /pmc/articles/PMC9185500/ /pubmed/35680258 http://dx.doi.org/10.1136/bmjopen-2021-057159 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Immunology (Including Allergy)
Spit, Karlinde Amber
Scharff, Miranda
de Blok, Christel JM
Niessen, Frank B
Bachour, Yara
Nanayakkara, Prabath W
Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title_full Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title_fullStr Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title_full_unstemmed Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title_short Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
title_sort patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
topic Immunology (Including Allergy)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185500/
https://www.ncbi.nlm.nih.gov/pubmed/35680258
http://dx.doi.org/10.1136/bmjopen-2021-057159
work_keys_str_mv AT spitkarlindeamber patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy
AT scharffmiranda patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy
AT deblokchristeljm patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy
AT niessenfrankb patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy
AT bachouryara patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy
AT nanayakkaraprabathw patientreportedsystemicsymptomsinwomenwithsiliconebreastimplantsadescriptivecohortstudy